Charles S Berkman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles S Berkman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles S Berkman. Charles S Berkman is VP, Gen. Counsel & Secretary in LIGAND PHARMACEUTICALS INC ($LGND).
Latest Insider Trading Transactions of Charles S Berkman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 56.26 | 16,057 | 903,367 | 16,057 | |
| Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 4,556 | 0 | 31,989 | 27.4 K to 32 K (+16.61 %) |
| Jan 05 2015 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | P | 45.23 | 126 | 5,699 | 27,433 | 27.3 K to 27.4 K (+0.46 %) |
| Jul 01 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | P | 43.79 | 329 | 14,408 | 27,307 | 27 K to 27.3 K (+1.22 %) |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 21.92 | 1,666 | 36,519 | 8,894 | |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 9.96 | 347 | 3,456 | 0 | |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 14.47 | 486 | 7,032 | 1,134 | |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 66.93 | 486 | 32,528 | 26,978 | 27.5 K to 27 K (-1.77 %) |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 14.47 | 486 | 7,032 | 27,464 | 27 K to 27.5 K (+1.80 %) |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 66.93 | 1,666 | 111,505 | 26,978 | 28.6 K to 27 K (-5.82 %) |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 21.92 | 1,666 | 36,519 | 28,644 | 27 K to 28.6 K (+6.18 %) |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 66.93 | 347 | 23,225 | 26,978 | 27.3 K to 27 K (-1.27 %) |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 9.96 | 347 | 3,456 | 27,325 | 27 K to 27.3 K (+1.29 %) |
| May 28 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 66.89 | 4,667 | 312,176 | 26,978 | 31.6 K to 27 K (-14.75 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 21.92 | 4,584 | 100,481 | 10,560 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 21.00 | 1,166 | 24,486 | 0 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 16.14 | 1,000 | 16,140 | 0 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 10.05 | 4,779 | 48,029 | 0 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 9.96 | 1,736 | 17,291 | 347 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 14.47 | 2,000 | 28,940 | 13,130 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 74.42 | 20,000 | 1,488,400 | 20,000 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 42.90 | 386 | 16,559 | 4,947 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 14.47 | 1,230 | 17,798 | 1,620 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 14.47 | 2,000 | 28,940 | 31,645 | 29.6 K to 31.6 K (+6.75 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 9.96 | 1,736 | 17,291 | 29,645 | 27.9 K to 29.6 K (+6.22 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 74.50 | 1,736 | 129,332 | 27,909 | 29.6 K to 27.9 K (-5.86 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 74.50 | 1,230 | 91,635 | 29,645 | 30.9 K to 29.6 K (-3.98 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 14.47 | 1,230 | 17,798 | 30,875 | 29.6 K to 30.9 K (+4.15 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 74.50 | 4,779 | 356,036 | 29,645 | 34.4 K to 29.6 K (-13.88 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 10.05 | 4,779 | 48,029 | 34,424 | 29.6 K to 34.4 K (+16.12 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 74.50 | 4,584 | 341,508 | 29,645 | 34.2 K to 29.6 K (-13.39 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 21.92 | 4,584 | 100,481 | 34,229 | 29.6 K to 34.2 K (+15.46 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 74.50 | 1,000 | 74,500 | 29,645 | 30.6 K to 29.6 K (-3.26 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 16.14 | 1,000 | 16,140 | 30,645 | 29.6 K to 30.6 K (+3.37 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 74.50 | 1,166 | 86,867 | 29,645 | 30.8 K to 29.6 K (-3.78 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 21.00 | 1,166 | 24,486 | 30,811 | 29.6 K to 30.8 K (+3.93 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 74.50 | 386 | 28,757 | 29,645 | 30 K to 29.6 K (-1.29 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 42.90 | 386 | 16,559 | 30,031 | 29.6 K to 30 K (+1.30 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 2,500 | 0 | 29,645 | 27.1 K to 29.6 K (+9.21 %) |
| Jan 02 2014 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | P | 33.92 | 209 | 7,088 | 27,145 | 26.9 K to 27.1 K (+0.78 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 21.00 | 3,834 | 80,514 | 0 | |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 21.00 | 9,499 | 199,479 | 3,834 | |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 16.14 | 4,862 | 78,473 | 0 | |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 16.14 | 11,804 | 190,517 | 4,862 | |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 14.47 | 7,020 | 101,579 | 2,850 | |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 10.05 | 312 | 3,136 | 5,625 | |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 10.05 | 312 | 3,136 | 26,936 | 26.6 K to 26.9 K (+1.17 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 16.14 | 4,862 | 78,473 | 26,624 | 21.8 K to 26.6 K (+22.34 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 21.00 | 3,834 | 80,514 | 21,762 | 17.9 K to 21.8 K (+21.39 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 47.54 | 7,020 | 333,726 | 17,928 | 24.9 K to 17.9 K (-28.14 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 14.47 | 7,020 | 101,579 | 24,948 | 17.9 K to 24.9 K (+39.16 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 47.54 | 11,804 | 561,154 | 17,928 | 29.7 K to 17.9 K (-39.70 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 16.14 | 11,804 | 190,517 | 29,732 | 17.9 K to 29.7 K (+65.84 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 47.54 | 9,499 | 451,576 | 17,928 | 27.4 K to 17.9 K (-34.63 %) |
| Sep 04 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 21.00 | 9,499 | 199,479 | 27,427 | 17.9 K to 27.4 K (+52.98 %) |
| Aug 20 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 9.96 | 14,583 | 145,247 | 2,083 | |
| Aug 20 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 10.05 | 4,284 | 43,054 | 5,937 | |
| Aug 20 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 10.05 | 4,284 | 43,054 | 17,928 | 13.6 K to 17.9 K (+31.40 %) |
| Aug 20 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 42.63 | 14,583 | 621,732 | 13,644 | 28.2 K to 13.6 K (-51.66 %) |
| Aug 20 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 9.96 | 14,583 | 145,247 | 28,227 | 13.6 K to 28.2 K (+106.88 %) |
| Jul 01 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | P | 17.36 | 815 | 14,148 | 13,644 | 12.8 K to 13.6 K (+6.35 %) |
| May 13 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 26.66 | 4,000 | 106,640 | 12,829 | 16.8 K to 12.8 K (-23.77 %) |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 21.92 | 15,144 | 331,956 | 15,144 | |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 21.92 | 4,856 | 106,444 | 4,856 | |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 2,500 | 0 | 16,829 | 14.3 K to 16.8 K (+17.45 %) |
| Sep 10 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 18.77 | 4,249 | 79,754 | 14,329 | 18.6 K to 14.3 K (-22.87 %) |
| Jul 03 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | J | 10.12 | 1,250 | 12,654 | 18,578 | 17.3 K to 18.6 K (+7.21 %) |
Page: 1